Seroprevalence of hepatitis C among Mexican adults:: An emerging public health problem?

被引:48
作者
Valdespino, Jose Luis
Conde-Gonzalez, Carlos J.
Olaiz-Fernandez, Gustavo
Palma, Oswaldo
Kershenobich, David
Sepulveda, Jaime
机构
[1] IDyAC, Lab Biol & React Mexico Birmex, Mexico City 03100, DF, Mexico
[2] Inst Nacl Salud Publ, Mexico City, DF, Mexico
[3] Secretaria Salud Mexico, Mexico City, DF, Mexico
[4] Univ Nacl Autonoma Mexico, Fac Med, Mexico City 04510, DF, Mexico
来源
SALUD PUBLICA DE MEXICO | 2007年 / 49卷
关键词
hepatitis C; seroepidemiology; sexually transmitted infections; Mexico;
D O I
10.1590/S0036-36342007000900011
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Objective. Hepatitis C Virus (HCV) infection is becoming a chronic disease in 60-85% of individuals and,is a cause of hepatic cirrhosis and hepatocellular carcinoma. The objective of this study was to report the seroprevalence of HCV infection in a probabilistic sample of the Mexican population. Material and Methods. This study is based on information obtained from the National Health Survey conducted in 2000. A total of 21 271 sera randomly selected for anti-HCV and RNA of HCV was studied. It was performed at the National Institute of Public Health in 2005. Results. Seroprevalence of HCV antibodies was 1.4% (IC95% 1.1%-1.6%), of which 35.7% had active infection. Risk factors for infection were using heroine (RM = 9.8, IC: 2.1-41.4), being separated from his/her spouse (RM = 2.6, IC: 1.1-5.9), being a widower (RM= 2.2, IC: 1.1-4.3) and living in the northern states in the country (RM = 1.9, IC: 1.1-3.2). Conclusion. Results from this study indicate that HCV is an emerging public health problem in Mexico. Risk factors indicate that the main route of transmission is through transfusion of blood products (previous to 1996) and the second route is through usage of intravenous drugs and sexual practices.
引用
收藏
页码:S395 / S403
页数:9
相关论文
共 29 条
  • [1] Allen B, 2003, SALUD PUBLICA MEXICO, V45, pS594
  • [2] Alter Miriam J, 2003, MMWR Recomm Rep, V52, P1
  • [3] The prevalence of hepatitis C virus infection in the United States, 1988 through 1994
    Alter, MJ
    Kruszon-Moran, D
    Nainan, OV
    McQuillan, GM
    Gao, FX
    Moyer, LA
    Kaslow, RA
    Margolis, HS
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1999, 341 (08) : 556 - 562
  • [4] Alter MJ., 2003, MMWR Recomm Rep, V52, P1
  • [5] Alter MJ., 2003, MMWR RECOMM REP, V52, P1
  • [6] [Anonymous], 2002, NIH Consens State Sci Statements, V19, P1
  • [7] [Anonymous], 2003, ENCUESTA NACL SALUD
  • [8] The prevalence of hepatitis C virus infection in the United States, 1999 through 2002
    Armstrong, Gregory L.
    Wasley, Annemarie
    Simard, Edgar P.
    McQuillan, Geraldine M.
    Kuhnert, Wendi L.
    Alter, Miriam J.
    [J]. ANNALS OF INTERNAL MEDICINE, 2006, 144 (10) : 705 - 714
  • [9] Carreto-Vélez MA, 2003, SALUD PUBLICA MEXICO, V45, pS690
  • [10] *CDCP, 2001, HAP C WHAT CLIN OTH